ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
Dow Jones
38,675.68
1.18%
Brent Oil
83.245
0.58%
Bitcoin
63,860.59
-0.05%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Vivoryon Therapeutics Nv (0R3M) Quote

Vivoryon Therapeutics Nv

Vivoryon Therapeutics Nv (0R3M)

LSE
4.71
0.00
(0.00%)
Closed May 05 11:30AM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
4.71
Bid
0.00
Ask
0.00
Volume
1,046
0.00 Day's Range 0.00
4.71 52 Week Range 4.71
Market Cap
-
Previous Close
4.71
Open
-
Last Trade
5
@
0.769
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
6,949
Shares Outstanding
0.00
Dividend Yield
-
PE Ratio
-
Earnings Per Share (EPS)
-
Revenue
-
Net Profit
-

About Vivoryon Therapeutics Nv

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.vivoryon.com
Headquarters
Halle, Deu
Founded
1970
Vivoryon Therapeutics Nv is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker 0R3M. The last closing price for Vivoryon Therapeutics Nv was 4.71 €. Over the last year, Vivoryon Therapeutics Nv shares have traded in a share price range of 4.71 € to 4.71 €.

Vivoryon Therapeutics Nv currently has 0 shares outstanding.

0R3M Latest News

More News

Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates

Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and...

April 24 2024
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. to Report Full Year 2023 Financial Results and Operational Progress on April 24, 2024

Vivoryon Therapeutics N.V. to Report Full Year 2023 Financial Results and Operational Progress on April 24, 2024 Vivoryon Therapeutics N.V. to Report Full Year 2023 Financial Results and...

April 16 2024
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. Announces Changes to Board Composition

Vivoryon Therapeutics N.V. Announces Changes to Board Composition Vivoryon Therapeutics N.V. Announces Changes to Board Composition Halle (Saale) / Munich, Germany, March 15, 2024 – Vivoryon...

March 15 2024
UK Regulatory

Vivoryon Therapeutics N.V. Provides Update on VIVIAD Phase 2b Study of Varoglutamstat in Early Alzheimer’s Disease

Vivoryon Therapeutics N.V. Provides Update on VIVIAD Phase 2b Study of Varoglutamstat in Early Alzheimer’s Disease   Vivoryon Therapeutics N.V. Provides Update on VIVIAD Phase 2b Study of...

March 04 2024
UK Regulatory

Vivoryon Therapeutics N.V. to Host Investor Meetings in January 2024

Vivoryon Therapeutics N.V. to Host Investor Meetings in January 2024 Vivoryon Therapeutics N.V. to Host Investor Meetings in January 2024 Halle (Saale) / Munich, Germany, January 8, 2024 –...

January 08 2024
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. Reports Third Quarter 2023 Financial Results and Highlights Operational Progress

Vivoryon Therapeutics N.V. Reports Third Quarter 2023 Financial Results and Highlights Operational Progress Vivoryon Therapeutics N.V. Reports Third Quarter 2023 Financial Results and...

December 06 2023
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. to Report Q3 2023 Financial Results and Operational Progress on December 6, 2023

Vivoryon Therapeutics N.V. to Report Q3 2023 Financial Results and Operational Progress on December 6, 2023 Vivoryon Therapeutics N.V. to Report Q3 2023 Financial Results and Operational...

November 28 2023
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. to Present at Upcoming Investor Conference

Vivoryon Therapeutics N.V. to Present at Upcoming Investor Conference Vivoryon Therapeutics N.V. to Present at Upcoming Investor Conference Halle (Saale) / Munich, Germany, November 7, 2023...

November 07 2023
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. Provides Comprehensive Progress Report for Ongoing Varoglutamstat Clinical Program Following R&D Event and VIVA-MIND DSMB Dose Decision

Vivoryon Therapeutics N.V. Provides Comprehensive Progress Report for Ongoing Varoglutamstat Clinical Program Following R&D Event and VIVA-MIND DSMB Dose Decision Vivoryon Therapeutics...

October 26 2023
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. Reports Positive Outcome from Independent Data Safety Monitoring Board with Unanimous Decision for VIVA-MIND U.S. Study of Varoglutamstat in Alzheimer’s Disease to Proceed at Highest Investigated Dose

Vivoryon Therapeutics N.V. Reports Positive Outcome from Independent Data Safety Monitoring Board with Unanimous Decision for VIVA-MIND U.S. Study of Varoglutamstat in Alzheimer’s Disease to...

October 23 2023
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1004.714.714.71139934.71DE
4004.714.714.71123544.71DE
12004.714.714.7169494.71DE
26004.714.714.7142844.71DE
52004.714.714.7136844.71DE
156004.714.714.7129294.71DE
260004.714.714.7128764.71DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BENFBeneficient
$ 6.8001
(254.17%)
31.01M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M
SHOTWSafety Shot Inc
$ 0.45
(45.16%)
644
AIPArteris Inc
$ 8.185
(38.03%)
1.11M
RGFReal Good Food Company Inc
$ 0.85
(37.32%)
4.26M
MNDRMobile health Network Solutions
$ 3.33
(-84.91%)
18.76M
NUVOHoldco Nuvo Group DG Ltd
$ 2.00
(-57.54%)
1.04M
SPTSprout Social Inc
$ 28.82
(-40.15%)
13.47M
UNITUniti Group Inc
$ 4.441
(-26.35%)
21.07M
IPDNProfessional Diversity Network Inc
$ 1.29
(-24.12%)
662.59k
AAPLApple Inc
$ 183.38
(5.98%)
163.22M
SQQQProShares UltraPro Short QQQ
$ 11.08
(-5.94%)
154.59M
JAGXJaguar Health Inc
$ 0.3164
(7.91%)
142.47M
NKLANikola Corporation
$ 0.6526
(6.55%)
106.88M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M

Discussion

View Full Feed
Nemesis18 Nemesis18 4 minutes ago
Mate, this is not up to you to determine the outcome of significance. You impersonated as a former military serviceman, a long-term government employee with sole purpose to deceive the retailers and shake the faith of the retailers. You can disguise as a former CEO or even a doctor. But here you imp
NWBO
medicinecat medicinecat 6 minutes ago
https://www.tynker.com/_next/image/?url=https%3A%2F%2Fwww.tynker.com%2Fprojects%2Fscreenshot%2F584073d4949b56a40b8b456f%2Fthe-kids-and-the-grumpy-old-man.png&w=1080&q=75
RVVTF
Chartmaster Chartmaster 7 minutes ago
Stocks should catch fire this week cuz Powell was dovish, employment report weak! My 185 call now in the money!
AMZN
Doc logic Doc logic 7 minutes ago
laser777,

There are those who know that the markets are rigged, know they can’t do anything on their own to change it and have adjusted their investment strategy knowing that this is what is happening. There are opportunities to play along with their trades or set up speed bumps near
NWBO
Snd101 Snd101 7 minutes ago
Sure Kiwi,
Amarin will conduct/fund trial to get the so called real world data (same data acquired via reduce-it trial), just because it is your fantasy.

Similarly Santa will deliver a unicorn 🦄 to me this Christmas, that I will ride to work every day. And yes, this un
AMRN
awesomed007 awesomed007 7 minutes ago
Every post is spzi, how many hours a day… bashing?
SPZI
Chartmaster Chartmaster 9 minutes ago
Breakaway gaps and reversal weeks all over the charts!!!!! Big buyin OP!!!!
SPY
CoodBMoney CoodBMoney 10 minutes ago
Hey Jax, This site seems to have changed format and I cannot seem to find out how to go back to old screen. Not sure I will be able to post anymore as I was only able to open your message and reply to you. I also post about RHCO on Stocktwits so you might look there. If you know how to go back to
RHCO
HippyTrades HippyTrades 10 minutes ago
Like the imminent buyback 5 years ago....
AXXA
Chartmaster Chartmaster 10 minutes ago
Powell Dovish, Employment report week! Perfect setup for big bounce!!! 6 Trillion cash on sidelines!!!! Weeee!!!!
SPY
Chartmaster Chartmaster 11 minutes ago
Boom! Weekly Stochastics buy signal!!! Expect sharp rally higher!!! Holding July 520 calls! No brainer!!!
SPY
Shonnieville Shonnieville 11 minutes ago
No shade to Nates Foods but after the 8 billion dollar contract, the share prices isn't even half of the price of $spzi. Does anyone else know of anything else Nate is into besides oil? The share price should be more; correct? So, with the way JP is executing things, I say we wait until the wash cyc
SPZI
B402 B402 11 minutes ago
No Scam, fwiw,,,,,The Campaign delivered 10 pizzas

https://www.msn.com/en-us/news/politics/donald-trump-delivers-pizza-to-new-york-city-firefighters-in-post-court-campaign-stop/ar-AA1o5fC9

Trump visited the Fire Department of New York's (FDNY) Engine Co. 8, Ladder Co. 2
gshores gshores 12 minutes ago
LOL, there is the truth right there!! love it!

The fact is everyone that invested in spzi has made money, and will continue to imo.

We have a rare oppurtunity here and feel blessed to be part of it!

I am holding a nice stash and will continue to, very Bul
SPZI
toohot toohot 13 minutes ago
What about Bob? Ever see that movie about a mentally deranged individual that was totally incapable and incompetent about making his own decisions? Well, there’s some BIEL references here that mirrors that movie. True longs get it!!!
‘Nuff said!




BUY $B
BIEL
cdnboy cdnboy 13 minutes ago
https://x.com/stocks_me/status/1787251380597506125?s=46
RDAR
shermann7 shermann7 13 minutes ago
'Absolutely' More Bank Failures Coming; Will This Be Worse Than 2008? | Rick Rule - VIDEO

https://www.youtube.com/watch?v=RgC1qjBeNc8

Shermann
RedSox04 RedSox04 14 minutes ago
Soon!
TONR
mrkirby mrkirby 14 minutes ago
I'm getting my lawn chair and pop corn ready for your day of reconning. You should have listened to Mike years ago and just bought in when told you. Now you have nothing to show for your wasted time. No one is fooled.🐘🐘🐘🐘🐘🐂🐂🐂🐂&#
IFUS
nickypicky nickypicky 15 minutes ago
Using Business Wire for press releases is the cheapest way to issue a press release and is usually only used by small companies with budget concerns.
COIN
nickypicky nickypicky 15 minutes ago
Using Business Wire for press releases is the cheapest way to issue a press release and is usually only used by small companies with budget concerns.
COIN
dstock07734 dstock07734 15 minutes ago
The commentary within has zero impact on any outcome of significance.
Mate, this is not up to you to determine the outcome of significance. You impersonated as a former military serviceman, a long-term government employee with sole purpose to deceive the retailers and shake the faith of the r
NWBO
fink fink 16 minutes ago
I'd consider that a grand slam.
I'd even start buying TELL again

I damn sure pay the IRS for 2022. LOL
NHYF
skyrocketinsight skyrocketinsight 16 minutes ago
Why else would you buy stock!

Mark's quote:
people that are simply in it to gamble.

We are not in this (buying MIKP) to hand all our money over to Mark to lose it for us.
MIKP
biotech_researcher biotech_researcher 17 minutes ago
Only a $3.6 million market cap. There is no way out for this one.. even selling all of Françoise Rolexes isn’t gonna help.
NDRA

Your Recent History

LSE
0R3M
Vivoryon Therapeutics Nv
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved